Viewing Study NCT04084366

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:05 PM
Ignite Modification Date: 2026-01-27 @ 9:34 PM
Study NCT ID: NCT04084366
Status: TERMINATED
Last Update Posted: 2025-03-26
First Post: 2019-09-05
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors
Sponsor: OBI Pharma, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None antibody drug conjugate (ADC) View